Similar articles

• [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].

  Turpini R, Caliandro L, Cocchi A, Volpi F, Brusaioli G, Grignani G, Antognetti R. Turpini R, et al. Clin Ter. 1975 May 15;73(3):213-36. Clin Ter. 1975. PMID: 123842 Italian. No abstract available.
• [The use of glucuronyl-glucosamino-glycan sulfate (3GS) in the treatment of cerebral and peripheral athero-arteriosclerotic pathology].

  Ciammaichella A, Solitro A, Torcia L, Arcuri P. Ciammaichella A, et al. Clin Ter. 1978 Mar 15;84(5):509-21. Clin Ter. 1978. PMID: 648104 Italian. No abstract available.
• [Clearing and anti-platelet-aggregation effects of a heparinoid of natural origin].

  Marini U, Bastoni F, Gibelli A. Marini U, et al. Clin Ter. 1974 Oct 15;71(1):13-31. Clin Ter. 1974. PMID: 4138995 Italian. No abstract available.
• [Current problems of antithrombotic therapy].

  Liusov VA, Belousov IuB. Liusov VA, et al. Kardiologiia. 1981 Aug;21(8):5-17. Kardiologiia. 1981. PMID: 7026869 Review. Russian. No abstract available.
• [Hyperlipemia and hypofibrinolysis in arteriosclerotic disease].

  Prino G, Mantovani M. Prino G, et al. Boll Chim Farm. 1967 Feb;106(2):67-84. Boll Chim Farm. 1967. PMID: 4893083 Review. Italian. No abstract available.